BlueWind Medical Raises $64 Million
BlueWind Medical notes the funds to be used to support the ramp in their commercial footprint in anticipation of potential FDA marketing clearance for the RENOVA iStim implantable neuromodulation device.
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
BlueWind Medical notes the funds to be used to support the ramp in their commercial footprint in anticipation of potential FDA marketing clearance for the RENOVA iStim implantable neuromodulation device.
CognitiveCare Inc. to provide antenatal risk stratification AI Support for the Bill & Melinda Gates Foundation-funded Antenatal Research Collaborative
Ictero Medical advises funding will be used to continue product development and complete initial clinical testing.
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm ET
Florida / New York
Phone: 561.316.3330